floretyrosine f-18 · Telix · NDA 218592
Pixclara
Earliest generic entry, as listed
11 Sep 2031
Blocked by exclusivity: NCE.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 1 unexpired
| NCE | new chemical entity (5 years) | 11 Sep 2031 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 218592 · 001 · RLD | solution, intravenous | 5-300mCi/ML | 11 Sep 2031 |